Fundraising Foxリベロセラ株式会社
3 known investors
Find your way into リベロセラ株式会社
Sign up to see every warm intro you have to リベロセラ株式会社
- Paths you didn't know you had: your email and LinkedIn already hold routes to the リベロセラ株式会社 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LiberoThera is a drug discovery company using cell-free membrane protein preparation technology and non-natural amino acid incorporation technology to develop antibody-based therapeutics, including antibodies targeting GPCRs such as anti-CCR8. It operates through research alliances and partnerships in the biopharmaceutical field.
Founders & leadership
Investors · 3
Frequently asked questions
- What does リベロセラ株式会社 do?
- LiberoThera is a drug discovery company using cell-free membrane protein preparation technology and non-natural amino acid incorporation technology to develop antibody-based therapeutics, including antibodies targeting GPCRs such as anti-CCR8. It operates through research alliances and partnerships in the biopharmaceutical field.
- Who are リベロセラ株式会社's investors?
- リベロセラ株式会社's investors include MC Healthcare Ventures, Taiho Ventures, LLC, UTokyo Innovation Platform Co. Ltd..